|
Home | Submit Press Release | Advertise | Submit Website
(HomeGarden247.com, August 16, 2017 ) The North America market for nuclear medicine Radiopharmaceuticals Indsutry is estimated at $1.53 billion in 2015 and is expected to reach $2.60 billion by 2020, growing at a CAGR of 11.2%. Nuclear medicine falls under the field of Molecular imaging, which involves usage of minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease.
View Full Report @ http://www.marketdataforecast.com/market-reports/north-america-nuclear-medicine-radiopharmaceuticals-market-129/
Increasing incidence of chronic diseases such as cancer and cardiac ailments, huge technological advancements, escalating demand for SPECT and PET applications along with the growing public awareness for healthcare are the major factors fuelling the growth of Radiopharmaceuticals market. Further, Integration of X ray tomography (CT) into SPECT has recently emerged as an excellent diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market. Strict regulatory framework and reimbursement issues are the key factors blocking the growth of the market. In addition to the above factors shorter half-life of radiopharmaceuticals and competition from orthodox diagnostic procedures are also the key factors restraining the North America nuclear medicine Radioisotopes market.
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/north-america-nuclear-medicine-radiopharmaceuticals-market-129/request-sample
Market Segmentation
• By Type
o Diagnostic Radioisotopes
o SPECT
Technetium-99m
Thallium-201
Gallium-67
Iodine-23
Others
o PET
Fluorine-18
Rubidium-82
Others
• Therapeutic Radioisotopes
o Beta Emitters
Iodine-131
Yttrium-90
Samarium-153
Rhenium-186
Lutetium-177
Alpha Emitters
• Radium-223
o Brachytherapy
o Cesium-131
o Iodine-125
o Palladium-103
o Iridium-192
• By Application
o Cardiology
o Lymphoma
o Thyroid
o Neurology
o Oncology
o Others
Avail Discount @ http://www.marketdataforecast.com/market-reports/north-america-nuclear-medicine-radiopharmaceuticals-market-129/request-discount
Radiopharmaceuticals market is dominated by diagnostic radioisotopes with an estimated market share of 90 % while therapeutic radioisotopes contribute for around 10% of the market. Based on type of radioisotopes the market is segmented into Technetium-99m (TC-99m), Thallium-201 (TL-201), Fluorine-18, Iodine (I-123), Rubidium-82 (RB-82) and others. The F-18 market is mostly contributed by F-18 FDG tracers though this market is enriched with future tracers such as F-18 Florbetapir and F-18 Choline. The promising clinical outcomes of these tracers have gained the business interest of major research institutes and PET isotope players. Ga-68 and Rb-82 are two other potential isotopes in the PET diagnostic market, ensuring high growth of the diagnostics segment. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease are the most promising indications for the future PET radioisotopes market. United States is the largest consumer market for radioisotopes and Canada is the largest producer of Tc-99m.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/north-america-nuclear-medicine-radiopharmaceuticals-market-129
Some of the key players influencing the North America nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation,Positron Corporation,Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
Source: EmailWire.com
Submit Home & Garden Press Release | Submit Home & Garden website
|
|